Neogen | NEOG - Current Liabilities


Neogen reported $150.6M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Agilent USD 2.27B 35M Mar/2026
Avanos Medical USD 131.2M 34M Mar/2026
Bio-Rad Laboratories USD 917M 400M Mar/2026
Cerus USD 100.8M 12.37M Dec/2025
Danaher USD 7.46B 653M Mar/2026
Idexx Laboratories USD 1.3B 151.04M Mar/2026
Illumina USD 1.57B 19M Mar/2026
Integra LifeSciences USD 346.85M 109.14M Mar/2026
Neogen USD 150.6M 3.55M Dec/2025
OraSure Technologies USD 44.08M 4.29M Mar/2026
Pacific Biosciences Of California USD 65.36M 7.48M Mar/2026
Quidel USD 962.4M 3.7M Mar/2026
Rockwell Medical USD 10.95M 259K Jun/2025
STAAR Surgical USD 60.99M 7.51M Mar/2026
Thermo Fisher Scientific USD 14.62B 568M Mar/2026
Utah Medical Products USD 2.6M 413K Dec/2025
Zoetis USD 2.05B 182M Mar/2026